Novartis to spin off Alcon
Novartis has announced plans to spin off Alcon into a separately traded, stand-alone company. Source: AAO
- Posted on: Jun 29 2018
- Leave a response
Novartis has announced plans to spin off Alcon into a separately traded, stand-alone company. Source: AAO
This week, guppies give rival fish the stink eye, an Iowa clinic puts the IDx-DR screening tool to use and an experimental therapy for Stargardt disease receives an orphan drug designation in Europe. Source: AAO
This study by Douglas D. Koch and colleagues examined the effect of anterior chamber depth on the accuracy of 8 IOL formulas in patients with normal axial lengths. Source: AAO
An experimental treatment for proliferative diabetic retinopathy, emixustat hydrochloride, has shown promise in a phase 2 trial, according to a press release by Acucela. Source: AAO
This paper describes the presentation and outcomes of patients who developed endophthalmitis after intravitreal injection with VEGF inhibitors. Source: AAO
The iStent inject micro-invasive glaucoma surgery (MIGS) device is now approved for mild to moderate open-angle glaucoma in patients undergoing cataract surgery. Source: AAO
This retrospective case series describes 6 patients who developed diplopia and strabismus after undergoing functional endoscopic sinus surgery. Source: AAO
In this study, investigators used existing epidemiologic evidence to model the global prevalence of presbyopia and vision impairment from uncorrected presbyopia. Source: AAO
In this retrospective cohort study, researchers characterized the outcomes of patients who initially presented with optic neuritis (ON) based on their final diagnoses. Source: AAO
This phase 2 clinical trial (ReBUILD) evaluated the use of clemastine fumarate—a first-generation antihistamine capable of inducing oligodendrocyte differentiation—as a remyelinating therapy for patients with multiple sclerosis. Source: AAO
Tel: 518-580-0553
Get Directions »
Tel: 518-580-0553
Get Directions »
Tel: +1 (518) 580-0553
Get Directions »